Woman's World on MSN19h
Study: At-Home Device Eases Depression Symptoms for 50%
With nearly 20 percent of U.S. adults affected by depression, the prevalence of this mental health condition drives many to ...
Bioengineers shed light on dosing challenges for cancer immunotherapy
A team of Rice University bioengineers has developed a mathematical model that clarifies why interleukin-12 (IL-12)—a potent ...
The Wall Street Transcript23h
Psychedelic Drug Stock Picks: Professional Expert Equity Analyst Patrick Trucchio.
Expert analyst Patrick Trucchio has spent many years researching the psychedelic drug stock sector. Patrick Trucchio, CFA, is a Managing Director of Equity Research at H.C. Wainwright & Co. whose ...
Medpage Today on MSN1d
Psych Congress Roundup: Digital Tx for MDD; Esketamine Rooms; PA Contributions
Research presented at this year's Psych Congress meeting in Boston included a randomized trial of esketamine (Spravato) ...
BBC5d
Psychedelic frees up depressed brain, study shows
The results, based on brain scans of 60 people, mean the drug could treat depression in a unique way, the researchers say. Psychedelics are being studied to treat a range of mental health disorders.